Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
International Journal of Population Data Science|May 29, 2026
Data resource profile: Transforming Outcomes through Research in Cancer Healthcare in Victoria (TORCH-VIC)Fanny Franchini, Karen Trapani, Jennifer Soon, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 15, 2022
Comparing Modeling Approaches for Discrete Event Simulations With Competing Risks Based on Censored Individual Patient Data: A Simulation Study and Illustration in Colorectal CancerKoen Degeling, Maarten J IJzerman, Catharina G M Groothuis-Oudshoorn, et al.
Asia-Pacific Journal of Clinical Oncology|December 5, 2022
Real-world adjuvant chemotherapy treatment patterns and outcomes over time for resected stage II and III colorectal cancerYat Hang To, Koen Degeling, Melanie McCoy, et al.
Targeted Oncology|September 5, 2022
Comparing Survival Outcomes for Advanced Cancer Patients Who Received Complex Genomic Profiling Using a Synthetic Control ArmSophie O'Haire, Koen Degeling, Fanny Franchini, et al.
Cancer Epidemiology|October 15, 2018
Matching the model with the evidence: comparing discrete event simulation and state-transition modeling for time-to-event predictions in a cost-effectiveness analysis of treatment in metastatic colorectal cancer patientsKoen Degeling, Mira D Franken, Anne M May, et al.
Asia-Pacific Journal of Clinical Oncology|February 10, 2021
An inverse stage-shift model to estimate the excess mortality and health economic impact of delayed access to cancer services due to the COVID-19 pandemicKoen Degeling, Nancy N Baxter, Jon Emery, et al.
Pharmacoeconomics|June 5, 2021
Circulating Tumour DNA as a Potential Cost-Effective Biomarker to Reduce Adjuvant Chemotherapy Overtreatment in Stage II Colorectal CancerYat Hang To, Koen Degeling, Suzanne Kosmider, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 11, 2026
Clinical Utility of Exome Sequencing: Post-Exome Testing Decision Changes in the Management of Children with Suspected Rare Genetic DiseaseToni Tagimacruz, Trevor Adam Seeger, Koen Degeling, et al.
Applied Health Economics and Health Policy|January 20, 2025
Approaches to Incorporation of Preferences into Health Economic Models of Genomic Medicine: A Critical Interpretive Synthesis and Conceptual FrameworkHadley Stevens Smith, Dean A Regier, Ilias Goranitis, et al.
Health and Quality of Life Outcomes|July 22, 2020
Evaluation of the performance of algorithms mapping EORTC QLQ-C30 onto the EQ-5D index in a metastatic colorectal cancer cost-effectiveness modelMira D Franken, Anne de Hond, Koen Degeling, et al.
Pageof 4